Precigen Inc (NASDAQ: PGEN) has experienced a decline in its stock price by -5.99 compared to its previous closing price of 1.07. However, the company has seen a fall of -4.20% in its stock price over the last five trading days. prnewswire.com reported 2024-09-16 that GERMANTOWN, Md., Sept. 16, 2024 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat on Wednesday, September 18, 2024 from 9:45 to 10:15 AM ET at the 2024 Cantor Global Healthcare Conference taking place September 17 to 19, 2024 in New York.
Is It Worth Investing in Precigen Inc (NASDAQ: PGEN) Right Now?
The 36-month beta value for PGEN is also noteworthy at 1.66. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 1 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PGEN is 142.90M, and at present, short sellers hold a 9.12% of that float. The average trading volume of PGEN on September 20, 2024 was 999.41K shares.
PGEN’s Market Performance
The stock of Precigen Inc (PGEN) has seen a -4.20% decrease in the past week, with a -15.47% drop in the past month, and a -34.68% fall in the past quarter. The volatility ratio for the week is 6.26%, and the volatility levels for the past 30 days are at 6.06% for PGEN. The simple moving average for the past 20 days is -3.81% for PGEN’s stock, with a -27.20% simple moving average for the past 200 days.
Analysts’ Opinion of PGEN
Cantor Fitzgerald gave a rating of “Overweight” to PGEN, setting the target price at $7 in the report published on November 18th of the previous year.
PGEN Trading at -20.78% from the 50-Day Moving Average
After a stumble in the market that brought PGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.88% of loss for the given period.
Volatility was left at 6.06%, however, over the last 30 days, the volatility rate increased by 6.26%, as shares sank -10.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.72% lower at present.
During the last 5 trading sessions, PGEN fell by -4.29%, which changed the moving average for the period of 200-days by -17.62% in comparison to the 20-day moving average, which settled at $1.0400. In addition, Precigen Inc saw -24.93% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PGEN starting from Perez Jeffrey Thomas, who purchase 58,823 shares at the price of $0.85 back on Aug 09 ’24. After this action, Perez Jeffrey Thomas now owns 743,097 shares of Precigen Inc, valued at $50,000 using the latest closing price.
KIRK RANDAL J, the Director of Precigen Inc, purchase 23,529,411 shares at $0.85 during a trade that took place back on Aug 09 ’24, which means that KIRK RANDAL J is holding 64,547,214 shares at $19,999,999 based on the most recent closing price.
Stock Fundamentals for PGEN
Current profitability levels for the company are sitting at:
- -4.14 for the present operating margin
- 0.58 for the gross margin
The net margin for Precigen Inc stands at -1.43. The total capital return value is set at -1.63. Equity return is now at value -129.32, with -96.46 for asset returns.
Based on Precigen Inc (PGEN), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -11.03. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -6811.83.
Currently, EBITDA for the company is -82.25 million with net debt to EBITDA at 0.04. When we switch over and look at the enterprise to sales, we see a ratio of 14.45. The receivables turnover for the company is 19.42for trailing twelve months and the total asset turnover is 0.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.03.
Conclusion
In summary, Precigen Inc (PGEN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
